Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Receptor, Transforming Growth Factor-beta Type II MeSH Descriptor Data 2025


MeSH Heading
Receptor, Transforming Growth Factor-beta Type II
Tree Number(s)
D08.811.913.696.620.682.700.795
D12.776.476.563.795
D12.776.543.750.705.852.720.750
D12.776.543.750.750.400.820.875
Unique ID
D000077294
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077294
Scope Note
A transmembrane serine-threonine kinase that forms a heteromeric complex with TYPE I TGF-BETA RECEPTORS when bound to TGF-BETA. This receptor complex regulates a variety of physiological and pathological processes including CELL CYCLE ARREST; CELL PROLIFERATION; CELL DIFFERENTIATION; WOUND HEALING; EXTRACELLULAR MATRIX production, immunosuppression and ONCOGENESIS.
Entry Term(s)
TGF-beta Type II Receptor
TGF-beta Type II Receptors
TGFBR2
TbetaR-II Kinase
Transforming Growth Factor-beta Type II Receptor
Transforming Growth Factor-beta Type II Receptors
Type II TGF-beta Receptor
Type II TGF-beta Receptors
Registry Numbers
EC 2.7.11.30
Public MeSH Note
2019; see TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR 1993-2018; RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA TYPE II was indexed under PROTEIN-SERINE-THREONINE KINASES and RECEPTORS, TRANSFORMING GROWTH FACTOR BETA 1994-2018; and under RECEPTORS, ENDOGENOUS SUBSTANCES 1993
History Note
2019 (1993)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2021/05/21
Receptor, Transforming Growth Factor-beta Type II Preferred
page delivered in 0.175s